Search

The Spanish government has announced the public grants corresponding to the State Program for research, development and innovation call — geared towards societal challenges and called “Collaboration

Will also present at Jefferies 2020 Virtual London Healthcare Conference. CEO to participate in a Borderline Personality Disorder Day panel

Clinical Trial Application approved by Spanish Drug Agency

At Roche, Dr. Hoffmann was Head of Discovery Chemistry and Head of the Roche Postdoc Fellowship Program. Subsequently he served as Chief Scientific Officer and Executive VP at Zealand Pharma, Chief

In just over a year of history, the company has established itself as a leading driver in the biomedical innovation and entrepreneurship scene

Oryzon Genomics reported financial results for the third quarter of 2020 and provided an update on recent developments

“New technologies are a key element of digital transformation in the healthcare sector", Ricard Sagués, Business Development & Marketing Director at Asphalion

New investors include 4BIO Capital, UPMC Enterprises, Jeito Capital and Ysios Capital

The OSD is an annual initiative whereby the company's employees devote part of their working hours to carry out activities that can have a positive impact on society

Paper describes mechanism of differentiation in patients and first antileukemic responses

Designating it as one of the most promising private biotechnology companies in the industry

Triple combination of iadademstat plus carboplatin-etoposide produced an objective response rate of 40% and mean average response of 4.5 months

Spain is ranked 9th in scientific production in biotechnology and has the highest percentage of scientific papers in high-impact journals of any country: 83.3%

The company will present at several reputed international conferences in September, all of them to be held virtually

The first product to be developed will be a point-of-care rapid diagnostic test to identify pigs who have been exposed to the African Swine Fever Virus (ASFV)

This round completes an initial seed round of €2.7 million ($3.1M) brought by Invivo and CDTI-Innvierte in December 2019 and in June 2020 respectively. The total funds raised by Arthex since inception

A biotechnology startup that develops and produces viral vectors to be applied in gene therapy

Vaxdyn’s new vaccine against Gram-negative pathogens, if approved, would help curb the rising threat of drug resistant bacteria

Studies have shown that the CECT5713 strain of Lactobacillus Salivarius allowed pregnancies to be 66% effective in women with infertility of unknown cause

The Barcelona Science Park kicks off the 17th Batx2Lab, a pioneering programme which has inspired the STEM talent of more than 700 young people

VIVEbiotech, S.L. announces a collaboration with Xyphos Biosciences for the development its CAR-T™ cell therapy for people with hematological cancer.